UK Study Suggests Personalized Medicine May be the Future of Alzheimer’s Disease Treatment – UKNow

LEXINGTON, Ky. (Oct. 8, 2021) A recently released paper from the Department of Physiology and Sanders-Brown Center on Aging (SBCoA) at the University of Kentucky College of Medicine suggests that your genetics can influence your response to Alzheimers disease pathology.

The laboratory of Donna Wilcock, Ph.D., professor in the Department of Physiology and SBCoA associate director, investigated inflammation in human brain tissue from UKs Alzheimers Disease Research Center. Brain tissue was analyzed from individuals with different forms of the genetic risk factor, apolipoprotein E (ApoE).

ApoE comes in various forms including ApoE2, ApoE3 and ApoE4. ApoE2 is typically thought of as protective and reduces the risk of developing Alzheimers disease. ApoE3 is the most common form of the gene, while ApoE4 increases the risk and severity of Alzheimers disease.

This work, led by graduate student Courtney Kloske, found that individuals with ApoE4 had a reduced inflammatory response to Alzheimers disease pathology compared to individuals with ApoE3.

This finding contradicts data found from mouse work, highlighting the need to always confirm studies in both mouse and then human tissue, Wilcock said.

Because of the differing response depending on genotype, targeting inflammation in ApoE4 patients may not be the best approach according to our research, said Kloske. This work shows that your genetic makeup may influence your response to certain types of treatment for Alzheimers disease.

The Wilcock lab hopes this work will help contribute to moving treatments closer toward precision medicine.

This work was supported by the 1F31AG069372-01, 1RF1AG057754-01, and P30-AG028383 from the National Institute of Aging. None of this work would have been possible without the research volunteers and clinical investigators at the University of Kentucky Alzheimers Disease Research Center. This work is only the responsibility of the authors and does not reflect the official views of the National Institute of Aging.

Continue reading here:
UK Study Suggests Personalized Medicine May be the Future of Alzheimer's Disease Treatment - UKNow